Absence of SOCS3 in the Cardiomyocyte Increases Mortality in a gp130-Dependent Manner Accompanied by Contractile Dysfunction and Ventricular Arrhythmias
Author(s) -
Toshitaka Yajima,
Yoshiteru Murofushi,
Hanbing Zhou,
Stanley Park,
Jonathan Housman,
Zhaohua Zhong,
Michinari Nakamura,
Mitsuyo Machida,
KyungKuk Hwang,
Yusu Gu,
Nancy D. Dalton,
Tomoko Yajima,
Hideo Yasukawa,
Kirk L. Peterson,
Kirk U. Knowlton
Publication year - 2011
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.111.028498
Subject(s) - medicine , cardiology , socs3 , glycoprotein 130 , endocrinology , cytokine , interleukin 6 , cancer , suppressor
Suppressor of cytokine signaling-3 (SOCS3) is a key negative-feedback regulator of the gp130 receptor that provides crucial signaling for cardiac hypertrophy and survival; however, an in vivo role of SOCS3 regulation on cardiac gp130 signaling remains obscure.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom